{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:19Z","timestamp":1784043139677,"version":"3.55.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T00:00:00Z","timestamp":1453507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11892-015-0707-1","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T09:01:11Z","timestamp":1453539671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hyperglycemia and Diabetes Mellitus Following Organ Transplantation"],"prefix":"10.1007","volume":"16","author":[{"given":"Rodolfo J.","family":"Galindo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha","family":"Wallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,23]]},"reference":[{"key":"707_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2215\/CJN.05471008","volume":"4","author":"HA Chakkera","year":"2009","unstructured":"Chakkera HA, Weil EJ, Castro J, et al. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol. 2009;4:853\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"707_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-1-1","volume":"1","author":"MC Thomas","year":"2000","unstructured":"Thomas MC, Moran J, Mathew TH, et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol. 2000;1:1.","journal-title":"BMC Nephrol"},{"key":"707_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/TP.0b013e318293fcf8","volume":"96","author":"MR First","year":"2013","unstructured":"First MR, Dhadda S, Croy R, et al. New-onset diabetes after transplantation (nodat): an evaluation of definitions in clinical trials. Transplantation. 2013;96:58\u201364.","journal-title":"Transplantation"},{"key":"707_CR4","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","volume":"14","author":"A Sharif","year":"2014","unstructured":"Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14:1992\u20132000. This article represents the most recent updated guidelines regarding the diagnosis and treatment of post-transplant diabetes mellitus. The consensus meeting was held in September 8-9th, 2013.","journal-title":"Am J Transplant"},{"key":"707_CR5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metabol. 2002;87:978\u201382.","journal-title":"J Clin Endocrinol Metabol"},{"key":"707_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Berghe van den","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359\u201367.","journal-title":"N Engl J Med"},{"key":"707_CR7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"NICE-SUGAR Study Investigators","year":"2009","unstructured":"NICE-SUGAR Study Investigators et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283\u201397.","journal-title":"N Engl J Med"},{"key":"707_CR8","doi-asserted-by":"crossref","first-page":"SS3","DOI":"10.1097\/01.TP.0000069952.49242.3E","volume":"75","author":"J Davidson","year":"2003","unstructured":"Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75:SS3\u201324.","journal-title":"Transplantation"},{"key":"707_CR9","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8\u2013S16.","journal-title":"Diabetes Care"},{"key":"707_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/tri.12042","volume":"26","author":"S Shabir","year":"2013","unstructured":"Shabir S, Jham S, Harper L, et al. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transpl Int. 2013;26:315\u201321.","journal-title":"Transpl Int"},{"key":"707_CR11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/gfs583","volume":"28","author":"M Hecking","year":"2013","unstructured":"Hecking M, Werzowa J, Haidinger M, et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant. 2013;28:550\u201366.","journal-title":"Nephrol Dial Transplant"},{"key":"707_CR12","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2337\/dc12-2441","volume":"36","author":"M Hecking","year":"2013","unstructured":"Hecking M, Kainz A, Werzowa J, et al. Glucose metabolism after renal transplantation. Diabetes Care. 2013;36:2763\u201371.","journal-title":"Diabetes Care"},{"key":"707_CR13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ecl.2007.07.007","volume":"36","author":"PT Pham","year":"2007","unstructured":"Pham PT, Pham PC, Lipshutz GS, et al. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin N Am. 2007;36:873\u201390.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"707_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/oxfordjournals.ndt.a027841","volume":"13","author":"K Midtvedt","year":"1998","unstructured":"Midtvedt K, Hartmann A, Hjelmesaeth J, et al. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant. 1998;13:427\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"707_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-6143.2006.01646.x","volume":"7","author":"B Bayes","year":"2007","unstructured":"Bayes B, Granada ML, Pastor MC, et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant. 2007;7:416\u201322.","journal-title":"Am J Transplant"},{"key":"707_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02067.x","volume":"39","author":"DH Raalte van","year":"2009","unstructured":"van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Investig. 2009;39:81\u201393.","journal-title":"Eur J Clin Investig"},{"key":"707_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e31826e592e","volume":"95","author":"HA Chakkera","year":"2013","unstructured":"Chakkera HA, Mandarino LJ. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation. 2013;95:647\u201352.","journal-title":"Transplantation"},{"key":"707_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.tp.0000195770.31960.18","volume":"81","author":"M Araki","year":"2006","unstructured":"Araki M, Flechner SM, Ismail HR, et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mtor inhibitor drugs. Transplantation. 2006;81:335\u201341.","journal-title":"Transplantation"},{"key":"707_CR19","doi-asserted-by":"crossref","first-page":"40050","DOI":"10.1074\/jbc.M110.154955","volume":"285","author":"SA Soleimanpour","year":"2010","unstructured":"Soleimanpour SA, Crutchlow MF, Ferrari AM, et al. Calcineurin signaling regulates human islet beta-cell survival. J Biol Chem. 2010;285:40050\u20139.","journal-title":"J Biol Chem"},{"key":"707_CR20","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","volume":"62","author":"AD Barlow","year":"2013","unstructured":"Barlow AD, Nicholson ML, Herbert TP. Evidence for rapamycin toxicity in pancreatic \u03b2-cells and a review of the underlying molecular mechanisms. Diabetes. 2013;62:2674\u201382.","journal-title":"Diabetes"},{"key":"707_CR21","first-page":"CD010699","volume":"11","author":"P Masson","year":"2014","unstructured":"Masson P, Henderson L, Chapman JR, et al. Belatacept for kidney transplant recipients. Cochrane Database Syst Rev. 2014;11:CD010699.","journal-title":"Cochrane Database Syst Rev"},{"key":"707_CR22","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2337\/dc14-0663","volume":"37","author":"KL Hackman","year":"2014","unstructured":"Hackman KL, Snell GI, Bach LA. Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care. 2014;37:2919\u201325. This prospective longitudinal study evaluated glycemic status pre- and post-lung transplantation with the use of frequent oral glucose tolerance testing over time.","journal-title":"Diabetes Care"},{"key":"707_CR23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1681\/ASN.2011080835","volume":"23","author":"M Hecking","year":"2012","unstructured":"Hecking M, Haidinger M, D\u00f6ller D, et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol. 2012;23:739\u201349.","journal-title":"J Am Soc Nephrol"},{"key":"707_CR24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report--2013; focus theme: age. J Heart Lung Transplant. 2013;32:951\u201364.","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 1","key":"707_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12579","volume":"14","author":"AJ Matas","year":"2014","unstructured":"Matas AJ, Smith JM, Skeans MA, et al. OPTN\/SRTR 2012 annual data report: kidney. Am J Transplant. 2014;14 Suppl 1:11\u201344.","journal-title":"Am J Transplant"},{"key":"707_CR26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2215\/CJN.09481209","volume":"5","author":"HA Chakkera","year":"2010","unstructured":"Chakkera HA, Knowler WC, Devarapalli Y, et al. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol. 2010;5:1669\u201375.","journal-title":"Clin J Am Soc Nephrol"},{"key":"707_CR27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","volume":"3","author":"BL Kasiske","year":"2003","unstructured":"Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178\u201385.","journal-title":"Am J Transplant"},{"key":"707_CR28","doi-asserted-by":"crossref","first-page":"269096","DOI":"10.1155\/2013\/269096","volume":"2013","author":"AD Yadav","year":"2013","unstructured":"Yadav AD, Chang YH, Aqel BA, et al. New onset diabetes mellitus in living donor versus deceased donor liver transplant recipients: analysis of the UNOS\/OPTN database. J Transplant. 2013;2013:269096.","journal-title":"J Transplant"},{"key":"707_CR29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e3181d2fec1","volume":"89","author":"HT Kuo","year":"2010","unstructured":"Kuo HT, Sampaio MS, Ye X, et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network\/United Network for Organ Sharing database. Transplantation. 2010;89:1134\u201340.","journal-title":"Transplantation"},{"key":"707_CR30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1510\/icvts.2010.256321","volume":"13","author":"J Saraiva","year":"2011","unstructured":"Saraiva J, Sola E, Prieto D, et al. Diabetes as an outcome predictor after heart transplantation. Interact Cardiovasc Thorac Surg. 2011;13:499\u2013504.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"707_CR31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/TP.0b013e3181dd6bd9","volume":"89","author":"X Ye","year":"2010","unstructured":"Ye X, Kuo HT, Sampaio MS, et al. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Transplantation. 2010;89:1526\u201332.","journal-title":"Transplantation"},{"key":"707_CR32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ejcts.2008.01.050","volume":"33","author":"JE Ollech","year":"2008","unstructured":"Ollech JE, Kramer MR, Peled N, et al. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors. Eur J Cardiothorac Surg. 2008;33:844\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"707_CR33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","volume":"25","author":"VM Montori","year":"2002","unstructured":"Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25:583\u201392.","journal-title":"Diabetes Care"},{"key":"707_CR34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","volume":"62","author":"FG Cosio","year":"2002","unstructured":"Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: impact of post-transplant diabetes. Kidney Int. 2002;62:1440\u20136.","journal-title":"Kidney Int"},{"key":"707_CR35","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/00007890-200110150-00024","volume":"72","author":"MC Thomas","year":"2001","unstructured":"Thomas MC, Mathew TH, Russ GR, et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation. 2001;72:1321\u20134.","journal-title":"Transplantation"},{"key":"707_CR36","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","volume":"67","author":"FG Cosio","year":"2005","unstructured":"Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67:2415\u201321.","journal-title":"Kidney Int"},{"key":"707_CR37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.tp.0000259617.21741.95","volume":"83","author":"TE Burroughs","year":"2007","unstructured":"Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 2007;83:1027\u201334.","journal-title":"Transplantation"},{"key":"707_CR38","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2012-1979","volume":"97","author":"KL Hermayer","year":"2012","unstructured":"Hermayer KL, Egidi MF, Finch NJ, et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metabol. 2012;97:4399\u2013406. This study is a randomized controlled clinical trial in the renal transplant population evaluating a subcutaneous vs. intravenous insulin therapy regimen, showing no difference in delayed graft function, but increased hypoglycemia in the IV insulin therapy group.","journal-title":"J Clin Endocrinol Metabol"},{"key":"707_CR39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/TP.0000000000000123","volume":"98","author":"P Li","year":"2014","unstructured":"Li P, Hunt KJ, Taber DJ, et al. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014;98:632\u20139.","journal-title":"Transplantation"},{"key":"707_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1399-0012.1997.tb00816.x","volume":"11","author":"AJ Matas","year":"1997","unstructured":"Matas AJ, Gillingham KJ, Elick BA, et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transpl. 1997;11:259\u201364.","journal-title":"Clin Transpl"},{"key":"707_CR41","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","volume":"3","author":"RS Woodward","year":"2003","unstructured":"Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant. 2003;3:590\u20138.","journal-title":"Am J Transplant"},{"key":"707_CR42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.tp.0000250361.60415.96","volume":"82","author":"JI Moon","year":"2006","unstructured":"Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation. 2006;82:1625\u20138.","journal-title":"Transplantation"},{"key":"707_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jss.2007.02.019","volume":"140","author":"JB Ammori","year":"2007","unstructured":"Ammori JB, Sigakis M, Englesbe MJ, et al. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res. 2007;140:227\u201333.","journal-title":"J Surg Res"},{"key":"707_CR44","doi-asserted-by":"crossref","unstructured":"Darstein F, Konig C, Hoppe-Lotichius M et al. New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor. Eur J Intern Med. 2015.","DOI":"10.1016\/j.ejim.2015.05.018"},{"key":"707_CR45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/TP.0b013e3181c3c2ff","volume":"89","author":"A Wallia","year":"2010","unstructured":"Wallia A, Parikh ND, Molitch ME, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation. 2010;89:222\u20136.","journal-title":"Transplantation"},{"key":"707_CR46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/TP.0b013e31819cc3e6","volume":"87","author":"C Park","year":"2009","unstructured":"Park C, Hsu C, Neelakanta G, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87:1031\u20136.","journal-title":"Transplantation"},{"key":"707_CR47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4158\/EP10343.OR","volume":"17","author":"A Wallia","year":"2011","unstructured":"Wallia A, Parikh N, O\u2019Shea-Mahler E, et al. Glycemic control by a glucose management service and infection rates after liver transplantation. Endocr Pract. 2011;17:546\u201351.","journal-title":"Endocr Pract"},{"key":"707_CR48","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/liv.12770","volume":"35","author":"RS Hoehn","year":"2015","unstructured":"Hoehn RS, Singhal A, Wima K, et al. Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study. Liver Int. 2015;35:1902\u20139.","journal-title":"Liver Int"},{"key":"707_CR49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ajt.12494","volume":"14","author":"DA Axelrod","year":"2014","unstructured":"Axelrod DA, Dzebisashvili N, Lentine K, et al. Assessing variation in the costs of care among patients awaiting liver transplantation. Am J Transplant. 2014;14:70\u20138.","journal-title":"Am J Transplant"},{"key":"707_CR50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1053-2498(02)01219-6","volume":"22","author":"D Marelli","year":"2003","unstructured":"Marelli D, Laks H, Patel B, et al. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant. 2003;22:1091\u20137.","journal-title":"J Heart Lung Transplant"},{"key":"707_CR51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.athoracsur.2011.09.037","volume":"93","author":"A Kilic","year":"2012","unstructured":"Kilic A, Weiss ES, George TJ, et al. What predicts long-term survival after heart transplantation? An analysis of 9,400 ten-year survivors. Ann Thorac Surg. 2012;93:699\u2013704.","journal-title":"Ann Thorac Surg"},{"key":"707_CR52","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/S0828-282X(09)70071-6","volume":"25","author":"J Higgins","year":"2009","unstructured":"Higgins J, Pflugfelder PW, Kostuk WJ. Increased morbidity in diabetic cardiac transplant recipients. Can J Cardiol. 2009;25:e125\u20139.","journal-title":"Can J Cardiol"},{"key":"707_CR53","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/CIRCULATIONAHA.106.615708","volume":"114","author":"MJ Russo","year":"2006","unstructured":"Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation. 2006;114:2280\u20137.","journal-title":"Circulation"},{"key":"707_CR54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1053-2498(02)00567-3","volume":"22","author":"CC Lang","year":"2003","unstructured":"Lang CC, Beniaminovitz A, Edwards N, et al. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant. 2003;22:244\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"707_CR55","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ctr.12118","volume":"27","author":"C Garcia","year":"2013","unstructured":"Garcia C, Wallia A, Gupta S, et al. Intensive glycemic control after heart transplantation is safe and effective for diabetic and non-diabetic patients. Clin Transpl. 2013;27:444\u201354.","journal-title":"Clin Transpl"},{"key":"707_CR56","first-page":"965","volume":"32","author":"RD Yusen","year":"2013","unstructured":"Yusen RD, Christie JD, Edwards LB, et al. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: age. Am J Transplant. 2013;32:965\u201378.","journal-title":"Am J Transplant"},{"key":"707_CR57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.12561","volume":"14","author":"KL Hackman","year":"2014","unstructured":"Hackman KL, Bailey MJ, Snell GI, et al. Diabetes is a major risk factor for mortality after lung transplantation. Am J Transplant. 2014;14:438\u201345.","journal-title":"Am J Transplant"},{"key":"707_CR58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1445-5994.2008.01786.x","volume":"39","author":"RA Bradbury","year":"2009","unstructured":"Bradbury RA, Shirkhedkar D, Glanville AR, et al. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an \u2018orphan\u2019 area? A retrospective case\u2013control study. Intern Med J. 2009;39:384\u20138.","journal-title":"Intern Med J"},{"key":"707_CR59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcf.2011.10.005","volume":"11","author":"M Hofer","year":"2012","unstructured":"Hofer M, Schmid C, Benden C, et al. Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation. J Cyst Fibros. 2012;11:131\u20136.","journal-title":"J Cyst Fibros"},{"key":"707_CR60","doi-asserted-by":"crossref","unstructured":"Hayes D, Jr., Patel AV, Black SM et al. Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation. J Thorac Cardiovasc Surg. 2015.","DOI":"10.1016\/j.jtcvs.2015.06.041"},{"key":"707_CR61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2012;97:16\u201338.","journal-title":"J Clin Endocrinol Metabol"},{"key":"707_CR62","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","volume":"40","author":"J Jacobi","year":"2012","unstructured":"Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251\u201376.","journal-title":"Crit Care Med"},{"key":"707_CR63","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.2337\/dc15-S016","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Diabetes care in the hospital, nursing home, and skilled nursing facility. Diabetes Care. 2015;38:S80\u20135.","journal-title":"Diabetes Care"},{"key":"707_CR64","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","volume":"32","author":"ES Moghissi","year":"2009","unstructured":"Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119\u201331.","journal-title":"Diabetes Care"},{"key":"707_CR65","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/dc15-0303","volume":"38","author":"G Umpierrez","year":"2015","unstructured":"Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38:1665\u201372.","journal-title":"Diabetes Care"},{"key":"707_CR66","unstructured":"Desai K, Gandhi G, Shoraka A et al. Outcomes with intensive glycemic control in liver transplantation: a randomized controlled trial [abstract]. Diabetes. 2015;64 (suppl 1)."},{"key":"707_CR67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4158\/EP13354.OR","volume":"20","author":"A Wallia","year":"2014","unstructured":"Wallia A, Gupta S, Garcia C, et al. Examination of implementation of intravenous and subcutaneous insulin protocols and glycemic control in heart transplant patients. Endocr Pract. 2014;20:527\u201335.","journal-title":"Endocr Pract"},{"key":"707_CR68","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.transproceed.2010.05.156","volume":"42","author":"MT Keegan","year":"2010","unstructured":"Keegan MT, Vrchota JM, Haala PM, et al. Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients. Transplant Proc. 2010;42:2617\u201324.","journal-title":"Transplant Proc"},{"key":"707_CR69","doi-asserted-by":"crossref","unstructured":"Gupta S, Oakes DJ, Therasse A et al. Extreme insulin resistance following heart transplant. In: Boris Draznin, editor. Diabetes Case Studies: Real Problems, Practical Solutions. American Diabetes Association; 2015. 214\u20137","DOI":"10.2337\/9781580405713.58"},{"key":"707_CR70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP.12.6.641","volume":"12","author":"LR Schmeltz","year":"2006","unstructured":"Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006;12:641\u201350.","journal-title":"Endocr Pract"},{"key":"707_CR71","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1463-1326.2011.01474.x","volume":"13","author":"K Dungan","year":"2011","unstructured":"Dungan K, Hall C, Schuster D, et al. Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin. Diabetes Obes Metab. 2011;13:1130\u20135.","journal-title":"Diabetes Obes Metab"},{"key":"707_CR72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0148607112458526","volume":"37","author":"RN Dickerson","year":"2013","unstructured":"Dickerson RN, Wilson VC, Maish GO, et al. Transitional nph insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin. JPEN J Parenter Enteral Nutr. 2013;37:506\u201316.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"707_CR73","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/dc12-0578","volume":"35","author":"D Baldwin","year":"2012","unstructured":"Baldwin D, Zander J, Munoz C, et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care. 2012;35:1970\u20134.","journal-title":"Diabetes Care"},{"key":"707_CR74","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","volume":"96","author":"MG Burt","year":"2011","unstructured":"Burt MG, Roberts GW, Aguilar-Loza NR, et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metabol. 2011;96:1789\u201396.","journal-title":"J Clin Endocrinol Metabol"},{"key":"707_CR75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP08331.RAR","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15:469\u201374.","journal-title":"Endocr Pract"},{"key":"707_CR76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jhm.874","volume":"6","author":"SA Seggelke","year":"2011","unstructured":"Seggelke SA, Gibbs J, Draznin B. Pilot study of using neutral protamine hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med. 2011;6:175\u20136.","journal-title":"J Hosp Med"},{"key":"707_CR77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4158\/EP11371.OR","volume":"18","author":"SM Dhital","year":"2012","unstructured":"Dhital SM, Shenker Y, Meredith M, et al. A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients. Endocr Pract. 2012;18:712\u20139.","journal-title":"Endocr Pract"},{"key":"707_CR78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11892-015-0595-4","volume":"15","author":"KE Kreider","year":"2015","unstructured":"Kreider KE, Lien LF. Transitioning safely from intravenous to subcutaneous insulin. Curr Diab Rep. 2015;15:23.","journal-title":"Curr Diab Rep"},{"key":"707_CR79","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4158\/EP13471.RA","volume":"20","author":"GE Umpierrez","year":"2014","unstructured":"Umpierrez GE, Schwartz S. Use of incretin-based therapy in hospitalized patients with hyperglycemia. Endocr Pract. 2014;20:933\u201344.","journal-title":"Endocr Pract"},{"key":"707_CR80","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc10-1677","volume":"34","author":"DH Raalte van","year":"2011","unstructured":"van Raalte DH, van Genugten RE, Linssen MM, et al. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34:412\u20137.","journal-title":"Diabetes Care"},{"key":"707_CR81","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez GE, Gianchandani R, Smiley D, et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care. 2013;36:3430\u20135.","journal-title":"Diabetes Care"},{"key":"707_CR82","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.2337\/dc14-0479","volume":"37","author":"GE Umpierrez","year":"2014","unstructured":"Umpierrez GE, Reyes D, Smiley D, et al. Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care. 2014;37:2934\u20139.","journal-title":"Diabetes Care"},{"key":"707_CR83","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1001\/jama.2014.5951","volume":"311","author":"A Wallia","year":"2014","unstructured":"Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA. 2014;311:2315\u201325.","journal-title":"JAMA"},{"key":"707_CR84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11892-012-0346-8","volume":"13","author":"A Therasse","year":"2013","unstructured":"Therasse A, Wallia A, Molitch ME. Management of post-transplant diabetes. Curr Diab Rep. 2013;13:121\u20139.","journal-title":"Curr Diab Rep"},{"key":"707_CR85","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.2337\/dc15-S009","volume":"38","author":"American Diabees Association","year":"2015","unstructured":"American Diabees Association. Glycemic targets. Diabetes Care. 2015;38:S33\u201340.","journal-title":"Diabetes Care"},{"key":"707_CR86","unstructured":"U.S. Renal Data System Annual Data. Medications for diabetes control in the first six months post-transplant, 2009\u20132011. Atlas of chronic kidney disease and end-stage renal disease in the United States, 2013."},{"key":"707_CR87","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.00800209","volume":"4","author":"MF Moen","year":"2009","unstructured":"Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1121\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"707_CR88","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1464-5491.2003.01025.x","volume":"20","author":"G Biesenbach","year":"2003","unstructured":"Biesenbach G, Raml A, Schmekal B, et al. Decreased insulin requirement in relation to gfr in nephropathic type 1 and insulin-treated type 2 diabetic patients. Diabet Med. 2003;20:642\u20135.","journal-title":"Diabet Med"},{"key":"707_CR89","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181605ebf","volume":"85","author":"A Sharif","year":"2008","unstructured":"Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation. 2008;85:353\u20138.","journal-title":"Transplantation"},{"key":"707_CR90","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000148802.04879.27","volume":"79","author":"JW Alexander","year":"2005","unstructured":"Alexander JW, Metze TJ, McIntosh MJ, et al. The influence of immunomodulatory diets on transplant success and complications. Transplantation. 2005;79:460\u20135.","journal-title":"Transplantation"},{"key":"707_CR91","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc12-2067","volume":"36","author":"HA Chakkera","year":"2013","unstructured":"Chakkera HA, Weil EJ, Pham PT, et al. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care. 2013;36:1406\u201312.","journal-title":"Diabetes Care"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0707-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-015-0707-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0707-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T06:37:00Z","timestamp":1748759820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-015-0707-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,23]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s11892-015-0707-1","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,23]]},"article-number":"14"}}